Consumption of antidepressants has more than doubled in OECD countries over the past 20 years, and the often off-label use of these medicines to treat chronic pain conditions is believed to be contributing to the increase.
Many people are dealing with ongoing pain – about one in five globally – and yet drug options for treatment are limited and the potential harm of many medications may outweigh the benefits. Opioids
